About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
Symbol
Name
ID 		Ppargc1b
peroxisome proliferative activated receptor, gamma, coactivator 1 beta
MGI:2444934
52 phenotypes from 7 alleles in 7 genetic backgrounds
Export: Excel File
Allelic Composition
Genetic Background		 Annotated Term Reference
Ppargc1btm1.1Avp/Ppargc1btm1.1Avp
involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6 		abnormal metabolism J:116167
abnormal myocardial fiber mitochondrial morphology J:116167
abnormal skeletal muscle fiber mitochondrial morphology J:116167
abnormal white adipose tissue morphology J:116167
decreased body weight J:116167
decreased circulating cholesterol level J:116167
decreased circulating triglyceride level J:116167
decreased gonadal fat pad weight J:116167
decreased heart rate J:116167
decreased oxygen consumption J:116167
decreased white adipose tissue amount J:116167
hepatic steatosis J:116167
increased liver weight J:116167
increased white fat cell size J:116167
Ppargc1btm1.1Dpk/Ppargc1btm1.1Dpk
involves: 129X1/SvJ * FVB/N 		abnormal brown adipose tissue morphology J:137598
abnormal fat cell morphology J:137598
abnormal muscle physiology J:137598
normal adipose tissue phenotype J:137598
normal cardiovascular system phenotype J:137598
decreased survivor rate J:137598
decreased triglyceride level J:137598
impaired adaptive thermogenesis J:137598
impaired exercise endurance J:137598
normal muscle phenotype J:137598
postnatal lethality J:137598
Ppargc1btm1.1Javi/Ppargc1btm1.1Javi
Tg(Fabp4-cre)1Rev/?
involves: 129P2/OlaHsd * C57BL/6J 		abnormal brown fat cell morphology J:221221
abnormal mitochondrial physiology J:221221
abnormal oxidative phosphorylation J:221221
abnormal respiratory electron transport chain J:221221
abnormal tricarboxylic acid cycle J:221221
normal adipose tissue phenotype J:221221
normal behavior/neurological phenotype J:221221
decreased brown fat lipid droplet number J:221221
normal growth/size/body region phenotype J:221221
normal homeostasis/metabolism phenotype J:221221
increased brown adipose tissue amount J:221221
increased brown fat cell lipid droplet size J:221221
Ppargc1btm1.1Rev/Ppargc1btm1.1Rev
involves: 129 * C57BL/6J 		decreased circulating free fatty acids level J:120079
decreased circulating triglyceride level J:120079
decreased locomotor activity J:120079
normal homeostasis/metabolism phenotype J:120079
impaired adaptive thermogenesis J:120079
increased circulating free fatty acids level J:120079
increased circulating triglyceride level J:120079
increased liver triglyceride level J:120079
increased liver weight J:120079
macrovesicular hepatic steatosis J:120079
postnatal lethality, incomplete penetrance J:120079
Ppargc1btm1.2Rev/Ppargc1btm1.2Rev
Tg(Tek-cre)1Ywa/0
involves: 129/Sv * C57BL/6 * C57BL/6J * SJL 		abnormal osteoclast differentiation J:160910
decreased bone resorption J:160910
Ppargc1btm1Lowl/Ppargc1btm1Lowl
involves: C57BL/6 		abnormal mitochondrial morphology J:129775
abnormal mitochondrial physiology J:129775
increased liver triglyceride level J:129775
insulin resistance J:129775
Tg(Ckm-Ppargc1b)T37Brsp/0
FVB-Tg(Ckm-Ppargc1b)T37Brsp 		abnormal mitochondrial morphology J:118258
abnormal muscle physiology J:118258
abnormal skeletal muscle fiber type ratio J:118258
abnormal skeletal muscle morphology J:118258
decreased skeletal muscle fiber size J:118258
enhanced exercise endurance J:118258
skeletal muscle hypoplasia J:118258
Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
11/05/2024
MGI 6.24 		The Jackson Laboratory